https://www.selleckchem.com/pr....oducts/larotrectinib
7±780.3 10 3 /μL vs. 373.4±266.8 10 3 /μL, P =0.003) and sputum eosinophil count (15.2±23.9% vs. 8.3±15.4%, P =0.051) were higher, and the sputum neutrophil count (42.9±35.1% vs. 61.3±35.1%, P =0.057) was lower in the stable asthma group than in the unstable asthma group. CONCLUSION High blood and sputum eosinophil count can predict a good response to ICS treatment in terms of prevention of AE in individuals with newly diagnosed asthma. The sputum neutrophil count may be an effective predictor of response to ICS, even though furth
Like
Comment
Share
